$ADNT

Tiltmann Heather M sold $500K of ADNT

Tiltmann Heather M (EVP, CLO, CHRO & Secretary) sold 22,000 shares of Adient plc (ADNT) at $22.71 ($0.50M total) on 2026-06-04.

Original reporting
SEC EDGAR · Tiltmann Heather M
Published Jun 5, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 5, 2026, 8:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ADNT
Neutral
medium confidence
Mentioned
$ADNT
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ADNTNeutralLow
01

Why it matters

The disclosure updates insider activity records; traders may monitor for follow-on selling/buying patterns, but there is no new operational or financial information.

02

Market read

Primarily a sentiment/positioning datapoint; not a standalone fundamental catalyst.

03

What to watch

No 10b5-1 plan is cited, but the article also lacks context on compensation, tax events, or prior sale schedules—so interpreting intent is inherently uncertain.

Relevance 6/10Novelty 6/10Timing: after-hours SEC Form 4 filed today (2026-06-05) for a 2026-06-04 sale

Background

The article is an SEC Form 4 insider transaction disclosure for Adient plc (ADNT).

Company-level read

Ticker impact

$ADNTNeutralMedium confidence
Context

Adient officer sold 22,000 shares in an open-market transaction disclosed via SEC Form 4, signaling insider liquidity activity.

Expected impact

Low likelihood of a sustained price move; any reaction is likely small and short-lived.

Evidence & confidence

The filing is an officer S-sale with no 10b5-1 plan stated; however, Form 4 sales are common and the article provides no earnings/guidance or business-change information.

Market effects

Limited read-through to the auto-parts/industrial supply chain; this is company-specific insider liquidity data.

None indicated; filing is US-listed disclosure only.

Minimal; no deal, regulatory action, or operational change mentioned.

Counterpoint

An officer sale can be routine (tax/portfolio rebalancing) and may not reflect negative expectations, especially without any accompanying negative company news.

Key entities

  • Adient plc

    US-listed company whose officer disclosed an open-market sale of shares via SEC Form 4.

  • Tiltmann Heather M

    EVP, CLO, CHRO & Secretary who sold 22,000 ADNT shares at $22.71 on 2026-06-04.

Related articles

$ADNTMed

Adient misses earnings estimates despite stronger-than-expected revenue

Adient (NYSE:ADNT) reported Q3 adjusted EPS of $0.48, below the $0.57 consensus, while revenue rose to $3.93B versus a $3.7B forecast. The company cited about $32M in temporary headwinds and operational inefficiencies. Adient kept FY2026 guidance, expecting ~$15B revenue, and reported GAAP net income of $25M. Shares were down ~0.9% premarket.

$ADNTMedAI 8/10

Adient reports third quarter financial results; reaffirms earnings and FCF outlook for FY26

Adient (NYSE: ADNT) reported Q3 2026 results: GAAP net income of $25M and diluted EPS of $0.32, versus adjusted diluted EPS of $0.48. Adjusted EBITDA was $225M, roughly flat year over year despite about $32M of temporary headwinds. At June 30, 2026, gross debt was ~$2.4B, net debt ~$1.5B, and cash ~$924M. The company said it generated free cash flow and repurchased $30M of shares in Q3.

$ADNTMed

Adient plc (ADNT): Results of Operations and Financial Condition

Adient plc (ADNT) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a08052026adientexhibit991.htm EX-99.1 Document Exhibit 99.1 Appendix Page 1 Adient plc Condensed Consolidated Statements of Income (Loss) (Unaudited) Three Months Ended June 30, (in millions, except per share data) 2026 2025 Net sales $ 3,929 $ 3,741 Cost of sales 3,694

$ADNTLow

Adient plc (ADNT) Releases China Business Update

Adient plc (NYSE:ADNT) said in a May 20 China business update that since last year’s J.P. Morgan Summit it has received new bookings supporting sales growth. The company reported about $1.1 billion in annual business in FY2025 from four new auto brands, with ~70% from C-OEMs. It also noted a December 2025 JV via a 49% stake in SCI (Zhangjiakou) Co., Ltd.